Commentary: Why is there another dengue outbreak in Singapore despite all our efforts? – CNA


In a nutshell, though overall the prevalence of dengue has fallen over the years, we are more susceptible to getting infected if exposed to the virus and more adept at diagnosing infections.

Just as Singapore has turned a corner on COVID-19, we now face the threat of a major dengue outbreak. Saw Swee Hock School of Public Health’s Hannah Clapham and Alex Cook weigh in on why this still happens despite all our mosquito control efforts.

SINGAPORE: It never rains, but it pours. Just when COVID-19 cases in Singapore have fallen back to lower levels, we are experiencing yet another outbreak, this time of a more familiar foe – dengue. 

The number of cases reported so far this year has already exceeded the whole of 2021 and is already climbing towards the levels in 2020 when Singapore saw its worst dengue outbreak. 

Why is this happening despite efforts by the National Environment Agency (NEA) and the public in mosquito control?

To borrow terms we’ve become familiar with over the last two years of the COVID-19 pandemic, the effective reproductive number – the number of people infected by the mosquitoes infected by one dengue carrier – needs to be kept below 1 to curb transmission. And that isn’t currently happening.

We know some circumstantial factors that may be responsible for the current outbreak. The recent warm weather is conducive to mosquito population growth. DENV3, the current dominant serotype behind the large majority of cases now, has not circulated at such levels before 2021. 

But here are two broader factors we think are responsible for why outbreaks like the current one still persist: Ever lower population immunity and ever better diagnostics. Ironically, both are good problems to have.


A seeming paradox of dengue epidemiology in Singapore is that despite thousands of cases in recent years, immunity in the population is dropping. It seems to defy logic until you flip it around: Immunity is falling, so dengue can spread more easily.

Low levels of transmission over the last 50 years, thanks to community and government successes in vector control, mean that fewer people have been exposed to dengue. With more people susceptible, a single infected mosquito has more chances to pass on the virus, meaning that controlling the mosquito population has to be increasingly effective to get the same results. 

Every few years, NEA and the Health Sciences Authority screen residual blood donations for past dengue infection, and each time over the last decade they have done so, the prevalence has fallen. In 2004, about one in three 30-year-olds had had dengue before and this fell to about one in four by 2017. The fall was generally starker among those aged 45, with prevalence falling from about 74 per cent to 48 per cent.

So how do we reconcile the paradox of the falling prevalence of dengue with the large numbers of cases diagnosed in recent years?

The short answer is that we are better now at detecting dengue infections than in the past. The public is also on higher alert for potential infections, thanks to COVID-19. 

In a nutshell, though overall the prevalence of dengue has fallen over the years, we are more susceptible to getting infected if exposed to the virus and more adept at diagnosing infections.


Fortunately, there are long term technological solutions around the corner, the two most likely over the years ahead being the use of Wolbachia mosquitoes and dengue vaccination.

The data from the pilot field sites in Tampines and Yishun over the last few years suggest the approach is very successful in cutting mosquito populations there.

But at a pilot stage, the effects are mainly entomological – we see a tenfold reduction in the number of female mosquitoes around release sites.

As this strategy moves towards larger-scale implementation, the effects should start to manifest epidemiologically, and we should see falling dengue case counts around release sites, as has started to transpire around the earlier release sites in Yishun and Tampines, where NEA reported a fall in 2019 of up to 88 per cent in dengue incidence. 

During the COVID-19 pandemic, the world has shown it is capable of rapid investment and international collaboration to understand the biology, develop vaccines and learn how to control this new disease. 

The hope for those of us working in infectious diseases is that these successes could galvanise solutions to endemic diseases like dengue – a disease that has been around much longer but against which we have fewer tools. 

So while the recent rise in dengue cases may seem alarming, this is a reflection of past successes in vector control and better testing capabilities. Advances lie on the horizon and can take Singapore to the next stage of dengue control. But for now, let’s remain diligent in doing our mozzie wipeout while we work our way there. 

Hannah E Clapham is an Assistant Professor at the Saw Swee Hock School of Public Health, NUS. Alex R Cook is Vice Dean (Research) and Associate Professor at the same school.


This entry was posted in Uncategorized and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s